Burnham to crack down on vape and betting shops August 11, 2026 Andy Burnham is set to unveil a crackdown on vape and betting shops in a bid to boost British high streets, which the Prime Minister says have been “hollowed out” in recent decades. Burnham will on Tuesday set out plans to scrap the Blair-era “aim to permit” rule, which requires councils to accept planning applications [...]
Burnham should go on a ‘cost of doing business’ tour August 11, 2026 An alarming note from one of the City’s top economists warns that October’s Budget could see taxes rise by almost the same amount as they did last year when Rachel Reeves cooked up £26bn worth of fresh hikes. Ruth Gregory, Deputy Chief UK Economist at Capital Economics, suggests that higher taxes “perhaps worth up to [...]
Just Eat takes UK AI ordering tool across Europe August 11, 2026 Just Eat Takeaway is rolling out out its AI voice ordering tool across Europe after launching the feature in the UK earlier this year, as food delivery firms look for new ways to keep customers on their apps. The company has expanded the assistant to Poland, Spain, Austria, Italy, Belgium and Switzerland, alongside its existing [...]
Silence Therapeutics Announces Proposed Public Offering of $150 Million of American Depositary Shares August 10, 2026 Silence Therapeutics plc (“Silence” or the “Company”), a global clinical-stage biotechnology company developing novel short interfering RNA (“siRNA”) therapies, today announced that it has commenced an underwritten public offering of approximately $150 million of its American Depositary Shares (“ADSs”), each representing three ordinary shares of £0.05 each in the capital of the Company, in the [...]
We can’t all create jobs. But we can all create opportunities. August 10, 2026 Headlines about the challenges facing young people trying to secure their first meaningful job have become hard to ignore. And with exam results for our next generation of workers landing soon, Emily Shenton, co-founder of Arrival, an organisational performance consultancy whose social impact practice partners with corporates to help ambitious young people build careers and [...]
The World’s Largest AI Companies Built Deployment Arms This Year. Harbor Built One for Law August 10, 2026 Harbor Deploy is the first AI deployment offering built exclusively for law firms and corporate legal departments, bringing the embedded-engineering model now reshaping enterprise AI to the industry where confidentiality, professional judgment, and duty to the client are non-negotiable.
Lepas L8: China’s New SUV Means Business August 10, 2026 Is the UK’s SUV market ready for another Chinese challenger? Motoring journalist Tim Barnes-Clay takes a closer look at the new Lepas. Lepas, another new marque from automotive giant Chery – the company behind Omoda and Jaecoo – is positioning the L8 plug-in hybrid (PHEV) as a premium SUV that combines handsome styling, generous technology [...]
AT&T-Led Neutral-Host Network Powers New Connectivity Experience at Davis Wade Stadium August 10, 2026 AT&T customers at Mississippi State University’s Davis Wade Stadium in Starkville are getting a boost in wireless connectivity following the deployment of a new AT&T-led distributed antenna system, or DAS, powered by Airspan’s MobileAccess 6000 Digital platform. Led and owned by AT&T as a neutral-host network, the new DAS is designed to deliver high-capacity, multi-operator [...]
Cavendish taps top adviser to fend off foreign takeover interest August 10, 2026 Cavendish has drafted in advisers from a top corporate consultancy to help it fend off low-ball takeover bids amid a wave of consolidation in Britain’s financial services sector. Top brass at the boutique investment bank enlisted the help of specialists at Teneo last year, City AM can reveal, who conducted a valuation exercise to “support [...]
Silence Therapeutics Announces Positive Topline Results from Phase 2 SANRECO Trial of Divesiran in Polycythemia Vera, Supporting its Potential Best-in-Class Profile August 10, 2026 Trial met its primary endpoint, with a significantly higher proportion of clinical responders on divesiran (88%) compared to placebo (19%); placebo-adjusted response rate = 69% Both divesiran dose groups showed substantial primary endpoint efficacy; 93.8% response rate at Q6W and 81.3% response rate at Q12W Divesiran was observed to be well tolerated with no new safety findings Phase 3 PV trial evaluating divesiran Q12W vs. placebo anticipated to initiate in 1H’27 Investor conference call and webcast to be held today, August 10, 2026 at 8:00 a.m. ET